Baliazin V A, Moskalenko E P, Chernikova I V, Shepeleva L P
Zh Vopr Neirokhir Im N N Burdenko. 1987 May-Jun(3):26-30.
With the use of a system of serological reactions (PHAR) on the basis of erythrocytic diagnosticums in neurosurgical patients (58 with tumors of the brain, 11 with tumors of the spinal cord, 112 with tumor-like diseases of the brain, 50 with lesions of the spinal cord marked by a tumor-like course) and in a control group of individuals (100 donors and 30 patients with tumors of the mammary gland and intestine) results were produced which bore evidence of the high specificity of the methods for detecting signs of brain damage and determining the histological nature of tumors of the brain and spinal cord in most patients. For instance, the histological nature of the tumors was identified in the preoperative period in 79% of patients with intracranial and in 73% of those with intraspinal new growths.
在神经外科患者（58例脑肿瘤、11例脊髓肿瘤、112例脑肿瘤样疾病、50例呈肿瘤样病程的脊髓病变患者）中，基于红细胞诊断制剂使用血清学反应系统（PHAR），并与一个对照组（100名供血者以及30例乳腺和肠道肿瘤患者）进行对比，结果表明，该方法在大多数患者中检测脑损伤迹象以及确定脑和脊髓肿瘤组织学性质具有高度特异性。例如，术前79%的颅内肿瘤患者和73%的脊髓肿瘤患者的肿瘤组织学性质得以明确。
